Search

Search results

ReNeuron trial FAQs

You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.

A group of people standing in a room with exhibition stands behind them

Trusts and Foundations

Inherited retinal dystrophies (IRDs) are the leading cause of blindness in working-age people in the UK, and children as young as eighteen-months are regularly diagnosed.

Does gene therapy always have to be gene-specific?

Early 2020 marked an important milestone for the Retina UK community, when the first person with an inherited retinal condition received NHS treatment to potentially slow or even stop the progression of their sight loss.

Elizabeth Baio

Meet our volunteers: Elizabeth Baio

Elizabeth first heard about Retina UK (then the British Retinitis Pigmentosa Society) when our founder, Lynda Cantor MBE, spoke on BBC In Touch in early 1977. She went along to the charity’s AGM the same year and stayed in touch with Mary Guest, one of the speakers.

A machine with a digital display with a hand in a green glove pressing the screen with their index finger

Research grants

Retina UK aims not only to progress research along established threads, but to stimulate new thinking, encourage innovative approaches and nurture original ideas.